【24h】

Anterior optic neuropathy associated with adalimumab.

机译:前视神经病变有关adalimumab。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Our purpose was to report a case of anterior optic neuropathy with pupillary edema in a patient treated with the TNF-alpha-antagonist adalimumab. METHODS: We report the case of a 60-year-old woman with optic neuropathy in 1 eye after 6 months of treatment with adalimumab. RESULTS: The patient developed decreased visual acuity of the left eye. The ocular findings were left optic disc swelling and bleeding at the rim, superior visual field depression in both eyes and left afferent pupillary defect. Adalimumab was discontinued and the visual acuity recovered slowly. CONCLUSIONS: Like infliximab, the modern TNF-alpha antagonist adalimumab is associated with optic neuropathy. Ophthalmologists should thus be alert when seeing patients treated with adalimumab.
机译:目的:我们的目的是报告的前视神经病变与瞳孔水肿与TNF-alpha-antagonist病人治疗adalimumab。60岁的女人与视神经病变1眼与adalimumab后6个月的治疗。结果:病人减少视觉发展左眼的敏锐度。左视神经盘出血肿胀和在边缘,眼睛和优越的视野抑郁左侧瞳孔传入障碍。停药,视力恢复缓慢。tnf拮抗剂adalimumab相关联视神经病变。因此当看到患者保持警惕adalimumab。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号